Cyber Monday Sale: Save 30% or more on all our guides and exclusive bundle offers. Learn more

Efficacy And Safety Of Meriva®, A Curcumin-phosphatidylcholine Complex, During Extended Administration In Osteoarthritis Patients

Effect Increase
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 100
Sex Both Genders
Age Range 45-64
Body Types Overweight, Average
Notes for this study:
Curcumin, dosed at 1,000mg MERIVA (curcumin bound to phosphatidylcholine) taken in two divided dosages of 500mg, was safe and effective over a period of 8 months in alleviating clinical and biochemical symptoms of osteoarthritis in a population of middle-aged (43+/-2) persons with osteoarthritis.

Reductions were noted in IL-6 (27%), IL-1b (65%), and cell adhesion factors.

Full details on all 2 studies are available to Examine members — 30% off during our Cyber Monday sale.

Already a member? Log in now to access.